The Federal Government has reaffirmed its commitment to making Assistive technology (AT) accessible, safe, and affordable for ...

Soros Fund Management's 13F portfolio grew slightly to $6.70B in Q1 2025. Check out the significant new stakes and major ...

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...

An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to ...

The electronic health records market is experiencing robust growth, primarily driven by the increasing incidence of chronic diseases that require ong ...

Merck’s Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

Cancer researchers discovered how exercise really can be like a drug for colon cancer, and AstraZeneca's immunotherapy drug ...

Quantum computing company IonQ (NYSE:IONQ) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety and promising objective response rates in patients with few treatment choices ...

Databricks also announced updates to its Unity Catalog that expand support for Apache Iceberg — the open-source table format ...

Given its varied manifestation among individuals, Neurofibromatosis Type 1 (NF1), a genetic condition reportedly affecting one in every 3,000 people worldwide, has prompted health experts to ...